Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Full Electronic Product Information In EU May Have To Wait Until 2030

Executive Summary

A wide-ranging survey by Europe’s research-based pharma industry says moves towards replacing paper product information are gathering pace, although numerous challenges will need to be overcome.

You may also be interested in...



European Industry Calls For Move From Principles To Action On ePI

A survey of hospital pharmacists across Europe has found that the majority of the profession finds electronic product information beneficial, but technological shortcomings can act as a barrier to access.

EU Prepares To Pilot Electronic Product Information

The adoption of a new common standard opens the way to the implementation of EU-wide electronic formats for documents such as the summary of product characteristics and the patient information leaflet.

From Innovation Mindsets To Incentives And COVID-19 Lessons: How EU Pharma Legislation Should Evolve

If the EU wants to become a more competitive space for innovation it can take a few lessons from both the US and the COVID-10 pandemic, say European pharma industry representatives. Fostering better communication between regulators and companies is just one example.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS145504

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel